Tamaki K - Search Results

1

Elevated circulating soluble CD30 levels in patients with polymyositis/dermatomyositis.

Yazawa N, Ihn H, Yamane K, Kubo M, Fujimoto M, Kikuchi K, Soma Y, Tamaki K. Yazawa N, et al. Among authors: tamaki k. Br J Dermatol. 2001 Oct;145(4):676-8. doi: 10.1046/j.1365-2133.2001.04417.x. Br J Dermatol. 2001. PMID: 11703306 No abstract available.

2

Increased serum levels of soluble vascular cell adhesion molecule-1 and soluble E-selectin in patients with polymyositis/dermatomyositis.

Kubo M, Ihn H, Yamane K, Yazawa N, Kikuchi K, Soma Y, Tamaki K. Kubo M, et al. Among authors: tamaki k. Br J Dermatol. 2000 Aug;143(2):392-8. doi: 10.1046/j.1365-2133.2000.03668.x. Br J Dermatol. 2000. PMID: 10951151

3

Prevalence of 52-kd and 60-kd Ro/SS-A autoantibodies in Japanese patients with polymyositis/dermatomyositis.

Kubo M, Ihn H, Asano Y, Yamane K, Yazawa N, Tamaki K. Kubo M, et al. Among authors: tamaki k. J Am Acad Dermatol. 2002 Jul;47(1):148-51. doi: 10.1067/mjd.2002.121037. J Am Acad Dermatol. 2002. PMID: 12077598

4

Distribution of anti-p80-coilin autoantibody in collagen diseases and various skin diseases.

Fujimoto M, Kikuchi K, Tamaki T, Yazawa N, Kubo M, Ihn H, Sato S, Soma Y, Tamaki K. Fujimoto M, et al. Among authors: tamaki k, tamaki t. Br J Dermatol. 1997 Dec;137(6):916-20. Br J Dermatol. 1997. PMID: 9470907

5

Serum concentrations of vascular endothelial growth factor in collagen diseases.

Kikuchi K, Kubo M, Kadono T, Yazawa N, IHN H, Tamaki K. Kikuchi K, et al. Among authors: tamaki k. Br J Dermatol. 1998 Dec;139(6):1049-51. doi: 10.1046/j.1365-2133.1998.02563.x. Br J Dermatol. 1998. PMID: 9990370

6

Prevalence and antigen specificity of anti-histone antibodies in patients with polymyositis/dermatomyositis.

Kubo M, Ihn H, Yazawa N, Sato S, Kikuchi K, Tamaki K. Kubo M, et al. Among authors: tamaki k. J Invest Dermatol. 1999 May;112(5):711-5. doi: 10.1046/j.1523-1747.1999.00580.x. J Invest Dermatol. 1999. PMID: 10233761 Free article.

7

Dermatomyositis with elevated serum hyaluronate.

Kubo M, Ihn H, Matsukawa A, Kikuchi K, Tamaki K. Kubo M, et al. Among authors: tamaki k. Clin Exp Dermatol. 1999 Jul;24(4):275-8. doi: 10.1046/j.1365-2230.1999.00478.x. Clin Exp Dermatol. 1999. PMID: 10457129

8

Circulating levels of soluble CD30 are increased in patients with localized scleroderma and correlated with serological and clinical features of the disease.

Ihn H, Yazawa N, Kubo M, Yamane K, Sato S, Fujimoto M, Kikuchi K, Soma Y, Tamaki K. Ihn H, et al. Among authors: tamaki k. J Rheumatol. 2000 Mar;27(3):698-702. J Rheumatol. 2000. PMID: 10743811

9

Serum levels of tissue inhibitor of metalloproteinase-1 and 2 in patients with eosinophilic fasciitis.

Jinnin M, Ihn H, Yamane K, Asano Y, Yazawa N, Tamaki K. Jinnin M, et al. Among authors: tamaki k. Br J Dermatol. 2004 Aug;151(2):407-12. doi: 10.1111/j.1365-2133.2004.06062.x. Br J Dermatol. 2004. PMID: 15327548

10

Serum levels of anti-agalactosyl IgG antibodies in mixed connective tissue disease.

Mimura Y, Ihn H, Jinnin M, Asano Y, Yamane K, Yazawa N, Tamaki K. Mimura Y, et al. Among authors: tamaki k. Br J Dermatol. 2005 Apr;152(4):806-7. doi: 10.1111/j.1365-2133.2005.06478.x. Br J Dermatol. 2005. PMID: 15840122 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,193 results

Search Page

Filters